• Breast cancer patients diagnosed by pathology;

⁃ EOOG score is 0 or 1;

‣ The age range for enrollment is between 18 and 75 years old; ④ Accept chemotherapy regimens based on taxane drugs (alone or in combination);

‣ ⑤ Previously received taxane chemotherapy for more than 6 months;

‣ ⑥ According to the National Cancer Institute (NCI) Common Terminology for Adverse Events (CTCAE) 5.0, reporting CIPN symptoms of grade 1 or higher for more than 2 weeks;

‣ ⑦ Voluntarily participate in this clinical trial and sign the informed consent form;

∙ Accept regular follow-up visits; ⑨ There is complete pathological data available.